SCI CHINA LIFE SCI 润色咨询

Science China-Life Sciences

出版年份:2010 年文章数:826 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:16.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-03-21 Judy Bright 来自安徽省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肺癌;小分子抑制剂
    经验分享:2023.03.16 投稿后状态变化记录:
    2023.03.17: Awaiting ED Assignment;
    2023.03.21 : Awaiting VEIC Assignment;
    目前是这样,,,

    30

    展开30条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-11-28 ms2000000932153408 来自北京

    请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-05-10 120a90fem13(暂无昵称)

    请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-08-02 淡忘Lrc 来自陕西省

    这个杂志如何提交原始数据?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-04-25 ms1000001579516810

    偏重的研究方向:细胞生物学
    经验分享:一直显示awaiting ED assignment多久会有#期刊论坛#下一步啊?

    21

    展开21条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-09-15 CasRx

    请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2017-12-14 hence

    投稿一个月还是Awaiting AE Assignment状态

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2020-08-26 1221128bm17暂无昵称

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-05-08 12280286m77(暂无昵称)

    这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌;小分子抑制剂<br>经验分享:2023.03.16 投稿后状态变化记录:<br>2023.03.17: Awaiting ED Assignment;<br>2023.03.21 : Awaiting VEIC Assignment;<br>目前是这样,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致,应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向:细胞生物学<br>经验分享:一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了,一直是waiting reviewer assignment的状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550003, encodeId=34f955000304, content=投稿一个月还是Awaiting AE Assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd142213913, createdName=hence, createdTime=Thu Dec 14 15:04:00 CST 2017, time=2017-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813431, encodeId=b2fe813431e9, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:这本期刊被我们单位定义为掠夺性期刊了,大家还建议投递吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/11/4811fcf6194ab0841f2d545b95c7d31e.jpg, createdBy=5d2f2303812, createdName=1221128bm17暂无昵称, createdTime=Wed Aug 26 14:18:15 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217769, encodeId=8228121e76903, content=这个杂志是OA吗?投稿要求说黑白的每页版面费是500元,彩印每页800-1000元。版面费是必须的,还是可以选择非OA,不用交版面费?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d232336682, createdName=12280286m77(暂无昵称), createdTime=Sun May 08 08:59:15 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104069, encodeId=c5af1104069a5, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    什么是MS?

    1

    展开1条回复
共94条页码: 1/10页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分